A mixture of U.S. Food and Drug Administration–approved monoaminergic drugs protects the retina from light damage in diverse models of night blindness

Authors

Henri Leinonen, University of California, Irvine
Elliot H. Choi, University of California, Irvine
Anthony Gardella, Case Western Reserve University
Vladimir J. Kefalov, Washington University School of Medicine in St. Louis
Krzysztof Palczewski, University of California, Irvine

Journal

Investigative Ophthalmology and Visual Science

Publication Date

2019

Volume

60

Issue

5

Inclusive Pages

1442-1453

Document Type

Open Access Publication

DOI

10.1167/iovs.19-26560

Rights and Permissions

Leinonen H, Choi EH, Gardella A, Kefalov VJ, Palczewski K. A mixture of U.S. Food and Drug Administration–approved monoaminergic drugs protects the retina from light damage in diverse models of night blindness. Invest Ophthalmol Vis Sci. 2019;60(5):1442–1453. https://doi.org/10.1167/iovs.19-26560 This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Leinonen, Henri; Choi, Elliot H.; Gardella, Anthony; Kefalov, Vladimir J.; and Palczewski, Krzysztof, "A mixture of U.S. Food and Drug Administration–approved monoaminergic drugs protects the retina from light damage in diverse models of night blindness." Investigative Ophthalmology and Visual Science. 60, 5. 1442-1453. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7771